Clinical Trials Directory

Trials / Completed

CompletedNCT00240773

A Safety and Effectiveness Study of Acetaminophen (4000 mg/Day) and Naproxen (750 mg/Day) in the Treatment of Osteoarthritis of the Hip or Knee

A Randomized, Double-Blind, Long-Term Comparative Study Evaluating the Safety and Efficacy of Acetaminophen (4000 mg/Day) and Naproxen (750 mg/Day) in the Treatment of Osteoarthritis of the Hip or Knee

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
581 (actual)
Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide · Industry
Sex
All
Age
40 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the long-term safety and effectiveness of acetaminophen (4000 mg per day) and naproxen (750 mg per day) in the treatment of osteoarthritis of the hip or knee.

Detailed description

This is a randomized, double-blind study to compare the long term safety profile and effectiveness of acetaminophen, given at a dose of 1000 mg every four to six hours, and naproxen, given at a dose of 375 mg twice daily (with matching placebo given four times daily to maintain the blind), in the treatment of osteoarthritis of the hip or knee. There are two groups of subjects. Group 1 has approximately 480 subjects randomized and a treatment duration of 12 months. Group 2 has approximately 80 subjects randomized and a treatment duration of 6 months. The primary measure of efficacy is the change from baseline in the WOMAC Osteoarthritis Index pain subscale at month 6. Safety evaluations, throughout the course of the study, include monitoring adverse events, laboratory tests and assessments of vital signs including respiration rate, pulse, blood pressure, and body weight. Subjects are instructed to take a dose of medication orally, every 4-6 hours. The acetaminophen subjects take a total daily dose of 4 g of acetaminophen. The naproxen subjects a total daily dose of 750 mg of naproxen. The treatment duration is 12 and 6 months in Group 1 and Group 2, respectively.

Conditions

Interventions

TypeNameDescription
DRUGacetaminophen4 grams daily for six months
DRUGnaproxen750 mg daily for 12 months
DRUGacetaminophen4 grams daily for 12 months
DRUGnaproxen750 mg daily for six months

Timeline

Completion
2003-06-01
First posted
2005-10-18
Last updated
2015-06-19

Source: ClinicalTrials.gov record NCT00240773. Inclusion in this directory is not an endorsement.